CGP-42112A

CGP-42112A is a potent angiotensin II receptor type 2 (AT2 receptor) agonist. It has a role as an angiotensin receptor agonist, a vasodilator agent, an antineoplastic agent, an anti-inflammatory agent and a neuroprotective agent.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CGP-42112A(CAS 127060-75-7)

CAT No: R1850

CAS No:127060-75-7

Synonyms/Alias:127060-75-7;Cgp 42112;Cgp-42112A;CGP-42112;CGP 42112A;Cgp 42112B;CGP42112A;CGP42112;MFCD00133611;9Q3V7W3XDD;CHEMBL1885579;L-Isoleucine, N-(1-(N-(N6-(N2-((phenylmethoxy)carbonyl)-L-arginyl)-N2-(N-(3-pyridinylcarbonyl)-L-tyrosyl)-L-lysyl)-L-histidyl)-L-prolyl)-;Nalpha-Nicotinoyl-Tyr-(Nalpha-Cbz-Arg)-Lys-His-Pro-Ile;(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-[[(2S)-3-(4-hydroxyphenyl)-2-(pyridine-3-carbonylamino)propanoyl]amino]hexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid;Nicotinic acid-tyr-(N(sigma)-benzyloxycarbonyl-arg)lys-his-pro-ile-OH;N6-(((benzyloxy)carbonyl)-L-arginyl)-N2-(nicotinoyl-L-tyrosyl)-L-lysyl-L-histidyl-L-prolyl-L-isoleucine;(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-[[(2S)-3-(4-hydroxyphenyl)-2-(pyridine-3-carbonylamino)propanoyl]amino]hexanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid;Nicotinic acid-tyrosyl-(N(sigma)-benzyloxycarbonyl-arginyl)lysyl-histidyl-prolyl-isoleucine-OH;[125I]CGP42112;[125I]-CGP42112;AngiotensinIIReceptorLigand;UNII-9Q3V7W3XDD;GTPL594;GTPL3944;SCHEMBL15524960;SCHEMBL16675400;DTXSID90155396;CHEBI:147302;EX-A7392;BDBM50514581;PDSP1_000402;PDSP2_000400;AKOS024457173;AKOS037648666;CGP-42112?;CS-3414;NCGC00167317-01;BS-15127;FA110425;HY-12405;CGP-42112A, >=95%, synthetic, solid;D83656;Q27075903;Angiotensin II Receptor Ligand Nicotinoyl-Tyr-Lys(Z-Arg)-His-Pro-Ile-OH;Angiotensin II Receptor Ligand (Nicotinoyl-Tyr-Lys(1)-His-Pro-Ile-OH.CbZ-Arg-(1));(2S,3S)-2-((S)-1-((5S,12S,15S)-15-((1H-Imidazol-5-yl)methyl)-5-(3-guanidinopropyl)-12-((S)-3-(4-hydroxyphenyl)-2-(nicotinamido)propanamido)-3,6,13-trioxo-1-phenyl-2-oxa-4,7,14-triazahexadecan-16-oyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid;(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-6-[(2S)-2-{[(BENZYLOXY)CARBONYL]AMINO}-5-CARBAMIMIDAMIDOPENTANAMIDO]-2-[(2S)-3-(4-HYDROXYPHENYL)-2-(PYRIDIN-3-YLFORMAMIDO)PROPANAMIDO]HEXANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-METHYLPENTANOIC ACID;L-ISOLEUCINE, N-(3-PYRIDINYLCARBONYL)-L-TYROSYL-N6-(N2-((PHENYLMETHOXY)CARBONYL)-L-ARGINYL)-L-LYSYL-L-HISTIDYL-L-PROLYL-;N(6)-[[(phenylmethoxy)carbonyl]-L-Arg-]-N(2)-[[(pyridin-3-yl)carbonyl]-L-Tyr-]-L-Lys-L-His-L-Pro-L-Ile-OH;N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridin-3-ylcarbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine;N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridine-3-carbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine;N-(3-PYRIDINYLCARBONYL)-L-TYROSYL-N6-(N2-((PHENYLMETHOXY)CARBONYL)-L-ARGINYL)-L-LYSYL-L-HISTIDYL-L-PROLYL-L-ISOLEUCINE;

Chemical Name:N6-(((benzyloxy)carbonyl)-L-arginyl)-N2-(nicotinoyl-L-tyrosyl)-L-lysyl-L-histidyl-L-prolyl-L-isoleucine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C52H69N13O11
M.W/Mr.
1052.2
Sequence
Three Letter Code:nicotinoyl-Tyr-Lys(1)-His-Pro-Ile-OH.Cbz-Arg-(1)
Appearance
White solid
Purity
≥95%
Activity
Potent AT2 angiotensin II receptor agonist.
Source#
Synthetic
Long-term Storage Conditions
Soluble to 1 mg/ml in water
Shipping Condition
Evaluation sample solution : ship with blue ice; All other available size: ship with RT , or blue ice upon request
InChI
InChI=1S/C52H69N13O11/c1-3-32(2)43(50(73)74)64-48(71)42-17-11-25-65(42)49(72)41(27-36-29-56-31-59-36)62-46(69)39(60-47(70)40(26-33-18-20-37(66)21-19-33)61-44(67)35-14-9-22-55-28-35)15-7-8-23-57-45(68)38(16-10-24-58-51(53)54)63-52(75)76-30-34-12-5-4-6-13-34/h4-6,9,12-14,18-22,28-29,31-32,38-43,66H,3,7-8,10-11,15-17,23-27,30H2,1-2H3,(H,56,59)(H,57,68)(H,60,70)(H,61,67)(H,62,69)(H,63,75)(H,64,71)(H,73,74)(H4,53,54,58)/t32-,38-,39-,40-,41-,42-,43-/m0/s1
InChI Key
UXGNARZDONUMMK-LRMQDCNJSA-N
Canonical SMILES
CCC(C)C(C(=O)O)NC(=O)C1CCCN1C(=O)C(CC2=CN=CN2)NC(=O)C(CCCCNC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C5=CN=CC=C5
Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)C5=CN=CC=C5

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide CDMOcGMP Peptide ServiceCustom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide Synthesis ServicesPeptide Modification ServicesEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers